Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer.

MLA

Stearns, Vered, et al. “Biomarker Modulation Following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 19, no. 14, July 2013, pp. 4008–16. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-13-0033.

APA

Stearns, V., Jacobs, L. K., Fackler, M., Tsangaris, T. N., Rudek, M. A., Higgins, M., Lange, J., Cheng, Z., Slater, S. A., Jeter, S. C., Powers, P., Briest, S., Chao, C., Yoshizawa, C., Sugar, E., Espinoza-Delgado, I., Sukumar, S., Gabrielson, E., & Davidson, N. E. (2013). Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 19(14), 4008–4016. https://doi.org/10.1158/1078-0432.CCR-13-0033

Chicago

Stearns, Vered, Lisa K Jacobs, Maryjo Fackler, Theodore N Tsangaris, Michelle A Rudek, Michaela Higgins, Julie Lange, et al. 2013. “Biomarker Modulation Following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 19 (14): 4008–16. doi:10.1158/1078-0432.CCR-13-0033.